Records of Clinical Experience and Other Unpublished Evidence Cited in CDC COVID-19 Treatment Options Document

Dr. Remington Nevin filed this request with the Centers for Disease Control and Prevention of the United States of America.
Due May 1, 2020
Est. Completion None
Status
Awaiting Response

Communications

From: Dr. Remington Nevin

To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

All records of clinical experience, anecdote, and other unpublished evidence that informed the decision to include use of chloroquine and hydroxychloroquine against COVID-19, as described by the U.S. Centers for Disease Control and Prevention in its document titled "Information for Clinicians on Therapeutic Options for COVID-19 Patients", published online March 21, 2020 at https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html, to include records related to the specific dosing schedules that "some U.S. clinicians have reported anecdotally" cited in the document.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Dr. Remington Nevin

From: Centers for Disease Control and Prevention

April 17, 2020

Request Number: 20-01158-FOIA

Dear Dr. Nevin: This is regarding your Freedom of Information Act (FOIA) request of April 6, 2020, for To Whom It May Concern:Pursuant to the Freedom of Information Act, I hereby request the following records:All records of clinical experience, anecdote, and other unpublished evidence that informed the decision to include use of chloroquine and hydroxychloroquine against COVID-19, as described by the U.S. Centers for Disease Control and Prevention in its document titled "Information for Clinicians on Therapeutic Options for COVID-19 Patients", published online March 21, 2020 at https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html, to include records related to the specific dosing schedules that "some U.S. clinicians have reported anecdotally" cited in the document.The requested documents will be made available to the general public, and this request is not being made for commercial purposes.In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.Sincerely,Dr. Remington Nevin.

Please see the attached letter.

Sincerely,
CDC/ATSDR FOIA Office
770-488-6399

From: Centers for Disease Control and Prevention

April 17, 2020

Request Number: 20-01158-FOIA

Dear Dr. Nevin: This is regarding your Freedom of Information Act (FOIA) request of April 6, 2020, for To Whom It May Concern:Pursuant to the Freedom of Information Act, I hereby request the following records:All records of clinical experience, anecdote, and other unpublished evidence that informed the decision to include use of chloroquine and hydroxychloroquine against COVID-19, as described by the U.S. Centers for Disease Control and Prevention in its document titled "Information for Clinicians on Therapeutic Options for COVID-19 Patients", published online March 21, 2020 at https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html, to include records related to the specific dosing schedules that "some U.S. clinicians have reported anecdotally" cited in the document.The requested documents will be made available to the general public, and this request is not being made for commercial purposes.In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.Sincerely,Dr. Remington Nevin.

Please see the attached letter.

Sincerely,
CDC/ATSDR FOIA Office
770-488-6399

Files

pages

Close